Damage Math

What this tab establishes

Consensus cut KKR's out-year earnings roughly 9.5% around the trigger. Market value fell $56.8 billion, 38.0%, from the January 2025 peak, and $11.1 billion, 10.7%, from the pre-trigger estimate vintage. A conservative two-scenario discounted-cash-flow puts the destroyed NPV at 9.3% if the hit is permanent and 1.5% if it is monetisation timing. The judges put the probability the impairment is temporary at 0.76. The gap is wide against the peak and thin against the trigger.

The near-term hit, quantified

The framework's numerator is how far forward earnings actually fell. Dated consensus vintages exist for FY2027 and FY2028 only; the 180-day vintage is 29 January 2026, four sessions before the 3 February repricing that opened the event leg described in Dislocation, so it brackets the trigger cleanly.

Source: consensus estimate vintages, 29 January and 28 July 2026; company-reported per-share basis reconciled to the FY2025 Annual Report segment table [1].

The company's own guidance moved over the same six months, and the record is precise. At its April 2024 investor day KKR set a 2026 adjusted-net-income target of $7-plus per adjusted share. On the 5 February 2026 call it was still reaffirmed conditionally: "presuming a constructive monetization environment, we also continue to feel confident that we can achieve $7-plus per share of adjusted net income. However, if the environment does deteriorate, we may delay some of our monetization activity… we'd be earning less in 2026, but… that would be in service of more earnings in 2027 and beyond" [2]. On 5 May 2026 the condition bound: "if you were handicapping our ability to reach $7 per share, we do think it is more likely that we land below that level. Importantly, if that were to happen, any delayed monetizations that impact 2026 would not be lost as we would expect them to shift to 2027 and beyond" [3].

Two things about that guidance change are worth stating exactly. It is not quantified — management said "below $7" and gave no replacement number [4]. And consensus was already below it: the FY2026 mean of $6.12 across 22 analysts sits 12.6% under the $7 anchor, so the sell side had discounted the target well before management withdrew it. Against FY2025 delivered adjusted net income of $4.87 per adjusted share [5], the FY2026 consensus is still 25.7% higher, and the FY2027 consensus of $7.35 is 51% higher. Forward earnings never fell below the last delivered year.

The price over the same window

Market capitalisation is derived here, because the deterministic feature file returns not_computable for it. The denominator is KKR's own adjusted share count — common stock plus vested exchangeable securities, the same base as its per-share earnings measures — taken from the disclosure nearest each date.

Sources: daily closes from the price record; weighted average adjusted shares of 893,849,528 (FY2024) and 901,069,396 (4Q'25) [6] and 901,461,945 (1Q'26) [7]; cross-checked against 891,550,894 shares of common stock outstanding at 24 February 2026 [8].

Peak to last: minus $56.79 billion, minus 38.0%. Pre-trigger to last: minus $11.06 billion, minus 10.7%. Peak to trough: minus $73.72 billion, minus 49.4%. The percentage on market value is fractionally shallower than on price because the adjusted share count rose 0.85% over the span.

Enterprise value moves nearly one-for-one with equity here, and consolidated EV is not the useful measure. KKR's balance sheet carried $39.88 billion of asset-management debt obligations at 31 December 2025, of which $30.23 billion is debt of consolidated collateralised financing entities — CLO notes secured on those vehicles' own assets — and $9.65 billion is financing facilities of consolidated funds [9]. Neither is a claim KKR services from its own earnings. KKR's own senior and subordinated notes totalled $9.37 billion of principal at 31 December 2025 against $8.58 billion a year earlier [10], and it issued $2.5 billion of Series D mandatory convertible preferred stock during 2025 [11]. On that basis enterprise value ran roughly $157.9 billion at the peak and $104.4 billion now — minus 33.9%, against minus 38.0% on equity — and minus 9.6% across the trigger window, against minus 10.7% on equity. Every measure below uses equity value, which is the tighter of the two.

Source: consensus vintages 29 January, 29 April, 28 June and 28 July 2026 (price taken at 26 June, the last session before the 28 June vintage date); closes from the price record.

The two lines separate hard through March and re-converge by July. At the 12 March trough the price was down 27.0% from the January vintage while the deepest estimate cut measurable by the next vintage was 9.6%, on FY2028. By 28 July the price is down 10.7% and the FY2027 cut is 9.6% — a spread of 110 basis points.

Two scenarios, and what each destroys

The question the framework asks is whether a small hit to near-term earnings destroyed a large share of the NPV of all future cash flows. The arithmetic below is a delta calculation, not a valuation: it compares the present value of the pre-cut consensus path against the post-cut path, so the answer does not depend on whether the absolute level is right.

Assumptions, all stated. Discount rate 10%, applied to adjusted net income per adjusted share, which is KKR's after-tax distributable measure. Explicit forecast FY2026 to FY2028 from consensus. Terminal value at end-FY2028 on a Gordon formula at 3% perpetual growth — conservative against a consensus FY2026-28 EPS compound rate of 18.6%. The pre-cut FY2026 figure is imputed by grossing the current $6.117 up by the 9.4% average out-year cut, since no FY2026 vintage exists; the FY2027 and FY2028 pre-cut figures are the actual 29 January vintages. Temporary means the FY2026-28 shortfall is deferred, so the terminal base reverts to the pre-cut FY2028 level and no catch-up earnings are credited. Permanent means the level shift persists, so the terminal base is the post-cut FY2028 level.

Source: derived from consensus estimate vintages of 29 January and 28 July 2026 at a 10% discount rate and 3% perpetual growth; per-share basis reconciled to reported adjusted net income per adjusted share [12].

The workings reproduce from the rows above. Explicit stage: 6.753/1.10 + 8.129/1.21 + 9.479/1.331 = 19.98 pre-cut, and 6.117/1.10 + 7.351/1.21 + 8.600/1.331 = 18.10 post-cut. Terminal: 9.479 × 1.03 / 0.07 = 139.48, discounted three years at 1.331 to 104.80; 8.600 × 1.03 / 0.07 = 126.54, discounted to 95.07.

• Permanent: minus $11.61 per share, minus 9.30%. A proportional level shift scales the whole path, so this figure is essentially discount-rate independent — it computes to minus 9.30% at 8%, 9%, 10% and minus 9.31% at 12%.
• Temporary: minus $1.89 per share, minus 1.51%. The deferral costs only the time value of three years of shifted cash. At 8% the cost is 1.11%; at 12%, 1.88%.
• Weighted at the trial's 0.76: 0.76 × 1.51% + 0.24 × 9.30% = 3.38%.

The gap, and the window it depends on

Source: derived — price damage from the market-value table above; NPV damage is 3.38% of the starting market value under the two-scenario model, weighted at the trial's p_temporary of 0.76.

On the trigger window the price destroyed $11.06 billion and the probability-weighted NPV damage is $3.50 billion, leaving a $7.56 billion gap, 7.3% of the pre-trigger market value. On the full drawdown the price destroyed $56.79 billion against $5.05 billion of weighted NPV damage — a $51.74 billion gap, 34.6% of the peak market value.

Those two answers are far apart, and the honest reading is that they measure different things.

The trigger-window gap nearly disappears under a pure permanent reading. If every dollar of the 9.3% cut is a permanent level shift, the NPV damage is $9.64 billion against $11.06 billion of price damage — a gap of $1.42 billion, 1.4% of the starting market value. Put plainly: judged only against the news it responded to, the market did not obviously overreact. The gap on that window exists only because the trial puts three-quarters of the weight on the shortfall being timing.

The full-drawdown gap is large but is not damage arithmetic. Over the eighteen months from the January 2025 peak, delivered earnings rose — adjusted net income per adjusted share went from $4.70 in FY2024 to $4.87 in FY2025 [13] — and forward consensus rose with them. The entire move is multiple: 35.5 times trailing adjusted net income per share at the peak, 13.7 times FY2026 consensus at the trough, 16.8 times now. That is a repricing of the growth-and-quality premium, not the market anchoring to an earnings cut. The framework's canonical damage-anchor setup — a guidance cut the stock tracks roughly one-for-one — is not what happened here.

The reverse arithmetic makes the point without any scenario. At $102.66 and a 10% discount rate, the consensus FY2026-28 path plus a terminal value implies perpetual growth of 2.2% beyond 2028. At the pre-trigger $114.98 on the pre-cut path it implied 2.3%. The market has been paying for roughly inflation-rate growth in perpetuity at both prices; what changed between January 2025 and today is that it stopped paying for much more than that.

The trial, and the ruling

The temporary-or-permanent question was argued by two opposing briefs, each citing the corpus, and ruled on by three judges reading in different orders, blind to this tab.

The case for temporary, at its strongest

The shortfall sits entirely in one line, and that line is a timing variable. FY2025 total operating earnings — the recurring block — rose 14.4% to $4,985.8 million, while total investing earnings fell 21.4% to $904.5 million; adjusted net income still rose 4.2% to $4,377.5 million [14]. Of the $246.4 million decline in investing earnings, $210 million is a single disclosed item: the Asian Fund II clawback, which KKR sized in advance and which no other fund's clawback exceeded [15]. Add it back and net realised performance income was $701.7 million against $608.8 million, up 15.3%.

The recurring engine accelerated through the drawdown. First-quarter 2026 management fees were $1,193 million, up 30%; fee-related earnings $1,016 million, up 24%, at a 69% margin; total operating earnings $1,325 million, up 19%; fee-paying assets under management $615 billion, up 17% [16]. Fee-related earnings per share were $1.13, up 23%, and 85% of trailing pre-tax segment earnings came from the recurring streams [17]. Client demand — the only direct test of franchise damage — set a record: $129 billion of new capital in 2025, "the highest fundraising year in our fifty-year history and almost double where we were as a firm two years ago", alongside total embedded gains of $19 billion at 31 December, a record and up 19% year on year [18]. Deferred exits are not lost exits: management put more than $1.2 billion of signed forward monetisation revenue on the table, "the largest forward monetization figure we've discussed on a call in our history" [19]. And the pattern has a precedent inside KKR's own record: fee-related earnings rose from $1,970.0 million in 2021 to $2,167.4 million in 2022 to $2,383.8 million in 2023 straight through a 48.4% peak-to-trough drawdown [20].

The case for permanent, at its strongest

KKR made its insurance exposure structural and irreversible. It bought the remaining 37% of Global Atlantic for approximately $2.7 billion in cash, taking ownership to 100% [21], and Global Atlantic now supplies $219 billion of KKR's $744 billion of assets under management [22]. That is spread income, not contracted fee income, and it earns a lower-quality dollar: FY2025 insurance revenue of $11.63 billion produced segment earnings of $1.11 billion, against asset-management revenue of $7.84 billion producing $4.55 billion [23].

The marginal return on that book is compressing, and management said so on the record. Liability-side competition is "very high", asset spreads are "as tight as they've been in a very long time", the combination is "putting some increased competitive pressure on ROEs", and KKR "pull[ed] back on the origination front in Q1" [24]. The remedy is not cost reduction but taking more duration risk: roughly 80% of first-quarter originations carried seven years of duration or more, against 37% for full-year 2024 [25]. The 10-K names what that costs in a bad state: higher rates "may result in increased surrenders on interest-sensitive products… as policyholders seek higher investment returns elsewhere", creating cash-flow mismatches [26], and a ratings downgrade can force capital raising or a change of business plan [27].

And the earnings the temporary case banks are marks, not cash. KKR recognises carried interest "as if the fair value of the underlying investments were realized as of the reporting date, irrespective of whether such amounts have been realized" [28]. Those fair values lean heavily on discounted cash flow: the weight ascribed to the discounted-cash-flow methodology was 55% for Level III private equity and 91% for Level III real assets at 31 December 2025 [29]. A reservoir measured that way is not the same asset as a signed exit.

The ruling

Source: the profile's adversarial diagnosis trial ruling (ruchir/trial/tally.json), three independent judges, order-randomised.

The judges put the probability the impairment is temporary at 0.76, with a per-seat range of 0.66 to 0.76 and a mean of 0.73. The result is not contested: the spread is 0.10, and reading order moved the answer by 0.05 — 0.76 when the temporary brief was read first, 0.71 when the permanent brief was. That probability is the report's diagnosis and this tab does not adjust it.

Two things about how the ruling was reached are worth carrying forward, because they bear on how much weight the losing side's evidence retains. The permanent brief's rebuttal exhibit — FY2025 GAAP net income falling to $2,370 million from $3,076 million — was discredited by two seats on its own source: the same one-page table shows pre-tax income rising 21.1% to $7,099 million on flat tax expense [30], so the decline sits below the pre-tax line in noncontrolling interests, not in earnings. Its strongest exhibit survived: two seats named the admitted Global Atlantic return-on-equity compression as the best-verified permanent evidence, and one recorded that it is why the probability stops well short of 0.9. On the other side, the temporary brief's forward-monetisation exhibit was cited to the wrong page — the quotes are verbatim and in context but sit on page 4, not page 3 — and one seat could not check the peer de-rating exhibit at all, so that comparison carries no verified weight in the ruling.

Which line broke, and whether it self-corrects

Driver-level consensus, on its 21 July 2026 vintage, isolates the break precisely. Of KKR's forecast operating lines, exactly one is modelled to fall in FY2026.

Source: driver-level consensus, vintage 21 July 2026; FY2025 comparatives reconcile to the FY2025 Annual Report segment table [31].

Fee-related earnings are modelled up 19.2% in FY2026 and up 60% by FY2028, at a margin widening from 69.2% to 70.6%; fee-paying assets under management from $602 billion to $867 billion. The line that falls is Global Atlantic: insurance operating earnings of $1,075 million in FY2026 against $1,109 million delivered in FY2025, minus 3.1%. Underneath it, the return on average equity the street models runs 11.4% in FY2025, 9.1% in FY2026, 10.2% in FY2027 and 11.6% in FY2028.

That shape is itself a claim about the mechanism: a 230 basis-point return trough in one year, 116 basis points back in the next, and above the FY2025 level by FY2028. The sell side is modelling a spread cycle, not a reset.

The repricing mechanism management describes is the annuity spread cycle in both directions: "when there is increased levels of volatility… we believe liabilities will become cheaper. And definitionally, you're going to see spreads come out on the asset side and so the ROE potential is outsized", backed by $6 billion of dry powder equity that "translates into $60-plus billion of buying power on the liability side" — and, on the same page, "we also know that that's not going to last forever" [32]. The second mechanism is monetisation timing rather than cost: gross realised carried interest is contracted to arrive when exits close, and management put more than $1.2 billion of signed forward monetisation revenue behind the shift [33].

The structural argument against is not that revenue is declining — it is not, on any line — but that the fix carries its own liability. Doubling long-duration originations from 37% to 80% [34] buys spread by lengthening the book into exactly the surrender and asset-liability exposures the 10-K describes [35]. Nothing in the corpus records a surrender, recapture or ratings event; the risk is conditional and disclosed, not realised.

Two facts cut against reading this as a fear dislocation, and both belong on the page. The sell side is not scared: 19 of 22 recommendations are buy or outperform, none are sell, and the mean target of $123.48 sits 20.3% above the last close (sell-side consensus, 28 July 2026). And KKR entered this drawdown priced as a consensus favourite at 35.5 times trailing adjusted earnings — so a large part of the 38% fall is the unwinding of that premium rather than a response to anything that went wrong.

What would change this read

The trial's own flip conditions are the falsifiers, and each is dated and checkable. Fee-related earnings per share falling below $1.13 for two consecutive quarters — second-quarter 2026 reports in early August, third-quarter in November — or fee-paying assets under management declining sequentially from $615 billion, would convert a timing story into fee compression. Total embedded gains falling below roughly $15 billion by the fourth-quarter 2026 results, from $18.3 billion at 31 March 2026 [36], without matching cash realisations, would mean the reservoir is being written down at marks rather than harvested. Insurance operating earnings declining year on year from $1,109 million, or any capital raise, ratings action or material surrender at Global Atlantic, would turn the conceded cyclical spread compression into a realised return reset. And FY2027 gross realised carry failing to exceed FY2026's would falsify the claim that delayed monetisations "would not be lost".

On the damage arithmetic specifically, the read here changes if a FY2026 consensus vintage from before the trigger turns up materially above the $6.75 imputed here — that would widen the measured cut and shrink the trigger-window gap further — or if the estimate cut continues past 9.5% without the price falling further, which would close the remaining gap from the other end.